A股異動 | 恆星科技(002132.SZ)漲停 擬新增建設年產1000萬KM超精細金剛線改擴建項目
格隆匯8月23日丨恆星科技(002132.SZ)今日走出“T字板”,報5.31元,收貨兩連板,總市值67億元。恆星科技公佈,金剛線主要應用於太陽能硅片、藍寶石等新型材料的切割,金剛線的應用市場與光伏行業的發展、藍寶石的應用、新型材料加工等密切相關。根據中國光伏業協會預計,“十四五”期間全球每年新增光伏裝機約 210-260GW,我國光伏年均新增裝機或將在 70-90GW 之間。隨着光伏裝機量的快速增長,金剛線市場需求廣闊。在此背景下,公司擬在原年產600萬KM超精細金剛線項目基礎上新增建設“年產1000萬KM超精細金剛線改擴建項目”。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.